Qvents
Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations
Home
About Us
Contact Us
Expert Panel
Tags
Qvents
Warning Letters
483s
Recalls
Import Alerts
Quality Insights
Tags
Forums
Learning Resources
Upcoming Trainings
Training Archives
Guidelines
Pharma Jobs
Job Openings
Post a Job
Jobs posted by me
Users & Profiles
News
Login/Register
Individual
Company
Home
About Us
Contact Us
Expert Panel
Tags
Qvents
Warning Letters
483s
Recalls
Import Alerts
Quality Insights
Tags
Forums
Learning Resources
Upcoming Trainings
Training Archives
Guidelines
Pharma Jobs
Job Openings
Post a Job
Jobs posted by me
Users & Profiles
News
Login/Register
Qualified person (QP) and Batch release related
Qvents
1 minute read
Uncategorized
Home
Guidelines
Qualified person (QP) and Batch release related
Updated on April 2, 2026
Home
Guidelines
Qualified person (QP) and Batch release related
Updated on April 2, 2026
Annex 16: Certification by a Qualified Person and Batch Release
(
EudraLex – Volume 4 – Good Manufacturing Practice (GMP) guidelines Annexes
)
Guidance for the template for the qualified person’s declaration concerning GMP compliance of active substance manufacture “The QP declaration template”
Template for the qualified person’s (QP) declaration concerning good manufacturing practice compliance of active substance manufacture “The QP declaration template” – Scientific guideline
&
Template
EU GMP guide annexes
:
Supplementary requirements: Annex 16
(Guidance on good manufacturing practice and good distribution practice: Questions and answers)
Europe CMDh
–
Mutual Recognition Procedure (MRP) and Decentralised Procedure (DCP) – Questions & Answers – QP Declaration
Tags :
EMA
Share:
Facebook
LinkedIn
Twitter
Search Posts
Latest Posts
Responding to FDA Form 483: USFDA Issues Guidance
April 2, 2026
Unichem Recalls Hypertension Tablets for Nitrosamine Impurity
February 16, 2026
Qvents Apps and Tools For QMS and GMP Processes
February 6, 2026
USFDA 483 to Pharmathen Flags Deficient Aseptic Operations
February 5, 2026
Imprimis Recall Unapproved Ophthalmic Injections for Glass Particulates in US
January 5, 2026